Physiologically Based Pharmacokinetic Modeling for Trimethoprim and Sulfamethoxazole in Children

DrugBank 5.0: a major update to the DrugBank database for 2018

(2017) David S Wishart et al.   NUCLEIC ACIDS RESEARCH

Pharmacologic studies in vulnerable populations: Using the pediatric experience

(2015) Kanecia Zimmerman et al.   SEMINARS IN PERINATOLOGY

Simultaneous determination of trimethoprim and sulfamethoxazole in dried plasma and urine spots

(2015) Daniel Gonzalez et al.   Bioanalysis

PharmGKB summary

(2014) Ellen M. McDonagh et al.   Pharmacogenetics and Genomics

A Workflow Example of PBPK Modeling to Support Pediatric Research and Development: Case Study with Lorazepam

(2013) A. R. Maharaj et al.   AAPS Journal

Activity of Tedizolid (TR-700) against Well-Characterized Methicillin-Resistant Staphylococcus aureus Strains of Diverse Epidemiological Origins

(2013) Kenneth S. Thomson et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Study on the Interaction Between Trimethoprim and Human Serum Albumin by Spectroscopic and Molecular Modeling Methods

(2013) Fengyu Deng et al.   SPECTROSCOPY LETTERS

Dosing Regimen Matters: the Importance of Early Intervention and Rapid Attainment of the Pharmacokinetic/Pharmacodynamic Target

(2012) Marilyn N. Martinez et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Regulatory Experience With Physiologically Based Pharmacokinetic Modeling for Pediatric Drug Trials

(2012) R Leong et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Influence ofNAT2Polymorphisms on Sulfamethoxazole Pharmacokinetics in Renal Transplant Recipients

(2011) Hideaki Kagaya et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and Children: Executive Summary

(2011) Catherine Liu et al.   CLINICAL INFECTIOUS DISEASES

Innovative clinical trial design for pediatric therapeutics

(2011) Matthew M Laughon et al.   Expert Review of Clinical Pharmacology

In Vitro Activity of Telavancin against a Contemporary Worldwide Collection of Staphylococcus aureus Isolates

(2010) R. E. Mendes et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Applications of Physiologically Based Pharmacokinetic (PBPK) Modeling and Simulation During Regulatory Review

(2010) P Zhao et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Prediction of the in vitro permeability determined in Caco-2 cells by using artificial neural networks

(2010) Paulo Paixão et al.   EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES

Prediction of Solubility and Permeability Class Membership: Provisional BCS Classification of the World’s Top Oral Drugs

(2009) Arik Dahan et al.   AAPS Journal

Challenges in conducting clinical trials in children: approaches for improving performance

(2009) Steven E Kern   Expert Review of Clinical Pharmacology